1. Puthiyottil N, Kanakkayil S, Pillai NP, Rajan A, Parambath SK, Krishnamurthy RG, Chatanathodi R, Menamparambath MM. In situ engineering of Au-Ag alloy embedded PEDOT nanohybrids at a solvent/non-solvent interface for the electrochemical enzyme-free detection of histamine. J Mater Chem B. 2023 Jan 16. doi: 10.1039/d2tb02637f. Epub ahead of print.

2. Rasha RP, Neelakandan AR, Krishna AP; Rajanikant GK, Mini Mol M. Nickel Hydroxide Nanoflake / Carbon Nanotube Composites for the Electrochemical Detection of Glutamic Acid using In Vitro Stroke Model. ACS Applied Nano Materials 2023;6:1347–59. doi: 10.1021/acsanm.2c04989.

3. Hafiza P, Jinsu V, Mithun CJ, Rajanikant GK, Cornelia MW, Minnatallah AY, Kaviyarasi R, Saikat D, Rupa S, Abhijit D, Anirban GM, Uddesh RW, Abilash VG, Alex G. Non-small cell lung carcinoma (NSCLC): Implications on molecular pathology and advances in early diagnostics and therapeutics. Genes and Diseases 2022; doi/10.1016/j.gendis.2022.07.023.

4. KS Akshay, VP Muhammad Rabeeh, Shebeer A Rahim, KP Sijina, GK Rajanikant, Hanas T. Electrophoretic deposition of Alginate/Bioglass composites: A strategy for tailoring biodegradation and biomineralization of Mg-Ca alloy. Surface and Coatings Technology 2022;448:128914. Doi: 10.1016/j.surfcoat.2022.128914.

5. Abhishek, Sijina KP, Rajanikant GK, Kuriachen B. Experimental Investigation into the effects of Electric Discharge Surface Modification Process Parameters on the Biocompatibility of Ti6Al4V. Biomedical Engineering Advances 2022;4:100063. Doi: 10.1016/j.bea.2022.100063

6. Das J, Mahammad FS, Krishnamurthy RG. An integrated chemo-informatics and in vitro experimental approach repurposes acarbose as a post-ischemic neuro-protectant. 3 Biotech 2022;12:71.

7. Rasha RP, Neelakandan AR, Muhammed FP, Rajanikant GK, Raghu C, Mini MM. Nickel cobaltite/multi-walled carbon nanotube flexible sensor for the electrochemical detection of dopamine released by human neural cells. Journal of Materials Chemistry C 2022;10:3048-60. doi: 10.1039/D1TC05400G.

8. Neelakandan AR, Ok-Nam B, Arshad M, Caglayan AB, Rajanikant G. K. Neuroprotective potential of Carnosine in cerebrovascular diseases. International Journal of Peptide Research and Therapeutics 2022;28:1-12.

9. Raghu SV, Kudva AK, Rajanikant GK, Baliga MS. Medicinal plants in mitigating electromagnetic radiation-induced neuronal damage: a concise review. Electromagnetic Biology and Medicine 2021;1-14.

10. Kim EH, Kim ES, Shin D, Kim D, Choi S, Shin YJ, Kim KA, Noh D, Caglayan AB, G.K. Rajanikant, Majid A, Bae ON. Carnosine protects against cerebral ischemic injury by inhibiting matrix-metalloproteinases. International Journal of Molecular Sciences 2021;22:7495-7508.

11. Kumari S, Kotyan S, Sugunan S, Rajanikant GK, Kothanahally S. Kumar S, Adiga SK, Dasappa JP, Kalthur G. The synthesis of a novel pentoxifylline derivative with superior human sperm motility enhancement properties. New Journal of Chemistry 2021;45:1072-1081.

12. Kumari S, Salian SR, Rao A, Somagond SM, Kamble RR, Nesaragi A, Das J, Rajanikant GK, Mutalik S, Raghu SV, Adiga SK, Kalthur G. Quinoline derivative enhances human sperm motility and improves the functional competence. Reproductive Biology 2021;28:1316-1332.

13. Devang N, Pani A, Rajanikant GK. Pseudokinases: Prospects for expanding the therapeutic targets armamentarium. Advances in Protein Chemistry and Structural Biology 2021;124:121-185.

14. Kumar R, Thanigaivelan R, Rajanikant GK, Jagadeesha T, Das J. Evaluation of Hydroxyapatite and Zinc coated Ti-6Al-4V surface for biomedical application using Electrochemical process. Journal of the Australian Ceramic Society 2021;57:107–116.

15. Davis CK, Rajanikant GK. Postischemic supplementation of Folic acid improves neuronal survival and regeneration in vitro. Nutrition Research 2020;75:1-14.

16. Nampoothiri SS, Rajanikant GK. miR-9 upregulation integrates post-ischemic neuronal survival and regeneration in vitro. Cellular and Molecular Neurobiology 2019;39:223-40.

17. Davis CK, Jain SA, Bae OK, Majid A, Rajanikant GK. Hypoxia mimetic agents for ischemic stroke. Frontiers in Cell Developmental Biology - Cellular Biochemistry 2019;6:175.

18. Salian SR, Nayak G, Kumari S, Patel S, Gowda S, Shenoy Y, Sugunan S, Rajanikant GK, Managuli RS, Mutalik S, Dahiya V, Pal S, Adiga SK, Kalthur G. Supplementation of biotin to sperm preparation medium enhances fertilizing ability of spermatozoa and improves preimplantation embryo development. Journal of Assisted Reproduction and Genetics 2019;36:255-66.

19. Suvanish Kumar VS, Pretorius E, Rajanikant GK. The synergistic combination of Everolimus and Paroxetine exerts post-ischemic neuroprotection in vitro. Cellular and Molecular Neurobiology 2018;38:1383-97.

20. Gopalakrishnan A, Shankarappa SA, Rajanikant GK. Hydrogel scaffolds: Towards restitution of ischemic stroke injured brain. Translational Stroke Research, 2019;10:1-18.

21. Das J, Rajanikant GK. Post-stroke depression: The sequelae of ischemic stroke. Neuroscience & Biobehavioral Reviews 2018;90:104-14.

22. Kim KA, Shin D, Kim JH, Shin YJ, Rajanikant GK, Majid A, Baek SH, Bae ON. Role of autophagy in endothelial damage and blood-brain barrier disruption in ischemic stroke. Stroke 2018;49:1571-79.

23. Kozhikkadan Davis C, Nasla K, Anjana AK, Rajanikant GK. Taxifolin as dual inhibitor of Mtb DNA gyrase and isoleucyl-tRNA synthetase: In silico molecular docking, dynamics simulation and in vitro assays. In Silico Pharmacology 2018:6:8.

24. Nampoothiri SS, Fayaz SM, Rajanikant GK. A novel 5-node feed-forward loop unravels miRNA-Gene-TF regulatory relationships in ischemic stroke. Molecular Neurobiology 2018:55;8251-62

25. Davis CK, Nampoothiri SS, Rajanikant GK. Folic acid exerts post-ischemic neuroprotection in vitro through HIF-1α stabilization. Molecular Neurobiology 2018:55;8328-45.

26. Neelakandan AR, Rajanikant GK. Commentary: Endophenotypes as disease modifiers: Decoding the biology of Alzheimer disease by genome-wide association studies. CNS & Neurological Disorders - Drug Targets 2018;17: 6-8.

27. Gokul S, Rajanikant GK. Circular RNAs in Brain Physiology and Disease. Advances in Experimental Medicine and Biology 2018;1087:231-237.

28. Gokul S, Rajanikant GK. Gokul S, Rajanikant GK. Research Highlights BAY 1436032: A Novel Pan-mutant IDH1 Inhibitor Extends Survival of Mice with Experimental Brain Tumors. CNS & Neurological Disorders - Drug Targets 2017;16: 636-7.

29. Fayaz SM, Rajanikant GK. Structure-based pharmacophore clustering of multi-conformation proteins: Application to identify novel and diverse CypD inhibitors. Current Proteomics 2017;14: 224-33

30. Sugunan S, Nampoothiri SS, Garg T, Krishnamurthy RG. Role of KCa3.1 channels in CNS diseases: A concise review. CNS & Neurological Disorders - Drug Targets 2016;15:1299-1305

31. Nampoothiri SS, Potluri T, Subramanian H, Krishnamurthy RG. Rodent Gymnastics: Neurobehavioral assays in ischemic stroke. Molecular Neurobiology 2017;54:6750-61.

32. Davis CK, Laud PJ, Bahor Z, Rajanikant GK, Majid A. Systematic review and stratified meta-analysis of the efficacy of carnosine in animal models of ischemic stroke. Journal of Cerebral Blood Flow & Metabolism 2016;36:1686-94.

33. Eslavath RK, Sharma D, Bin Omar NA, Chikati R, Teli MK, Rajanikant GK, Singh SS. β-N-oxalyl-l-α, β- diaminopropionic acid induces HRE expression by inhibiting HIF-prolyl hydroxylase-2 in normoxic conditions. European Journal of Pharmacology 2016;791:405-11.

34. Sinoy S, Fayaz SM, Charles KD, Suvanish VK, Kapfhammer JP, Rajanikant GK. Amikacin inhibits miR-497 maturation and exerts post-ischemic neuroprotection. Molecular Neurobiology 2017;54:3683-694.

35. Das J, Krishnamurthy RG. Commentary: Death Associated Protein Kinase 1: A Perp in Cerebral Ischemia. CNS & Neurological Disorders - Drug Targets 2016;15:874-7.

36. Nampoothiri SS, Krishnamurthy RG. Commentary: Targeted Inhibition of miR-155 Promotes Post-Stroke Neovascularization and Functional Recovery. CNS and Neurological Disorders - Drug Targets 2016;15:372-4.

37. Nampoothiri SS, Rajanikant GK. Decoding the ubiquitous role of microRNAs in neurogenesis. Molecular Neurobiology 2016;54:2003-11.

38. Fayaz SM, Suvanish Kumar VS, Davis CK, Rajanikant GK. Novel RIPK3 inhibitors discovered through a structure-based approach exert post-ischemic neuroprotection. Molecular Diversity 2016;20:719-28.

39. Kumar VS, Krishnamurthy RG. Commentary: Adaptive PTEN loss enhances the outgrowth of brain metastatic tumour cells. CNS and Neurological Disorders - Drug Targets 2016;15:262-4.

40. Fayaz SM, Rajanikant GK. Ensembling and Filtering: An Effective and Rapid In Silico Multi-Target Drug Design Strategy to Identify RIPK1 and RIPK3 Inhibitors. Journal of Molecular Modeling 2015;21:314-27.

41. Shashikumar S, Pradeep H, Chinnu S, Rajini PS, Rajanikant GK. Alpha-linolenic acid suppresses dopaminergic neurodegeneration and movement disorder induced by 6-OHDA in Caenorhabditis elegans. Physiology and Behavior 2015;151:563-69.

42. Fayaz SM, Rajanikant GK. Modelling the molecular mechanism of protein-protein interactions and their inhibition: CypD-p53 case study. Molecular Diversity 2015;19:931-943.

43. Thushara Vijayakumar N, Sangwan A, Sharma B, Majid A, Rajanikant GK. Cerebral ischemic preconditioning: The road so far… Molecular Neurobiology 2016;53:2579-93.

44. Nampoothiri SS, Menon HV, Das D, Krishnamurthy RG. ISCHEMIRs: Finding a way through the obstructed cerebral arteries. Current Drug Targets 2015;16:800-10.

45. Fayaz SM, Raj YV, Krishnamurthy RG. CypD: The Key to the Death Door. CNS and Neurological Disorders - Drug Targets 2015;14:1-10.

46. Jagetia GC, Rajanikant GK. Curcumin Stimulates the Antioxidant Mechanisms in Mouse Skin Exposed to Fractionated γ-Irradiation. Antioxidants 2015;4:25-41.

47. Fayaz SM, Suvanish Kumar VS, Rajanikant KG. Finding Needles in a Haystack: Application of Network Analysis and Target Enrichment Studies for the Identification of Potential Anti-Diabetic Phytochemicals. PLOS One 2014;9:e112911

48. Krishnmurthy RG, Shradgan FM. Commentary: USP30 regulates the mitophagy-mediated neuroprotection in Parkinson's disease. CNS and Neurological Disorders - Drug Targets 2014;13:1-2.

49. Fayaz SM, Rajanikant GK. ATF4: the perpetrator in axonal-mediated neurodegeneration in Alzheimer’s disease. CNS and Neurological Disorders - Drug Targets 2014;13:1483-4.

50. Fayaz SM, Rajanikant GK. Commentary: research highlights: IKKβ mediates Aβ-triggered microglial inflammation and neuronal death during Alzheimer's disease. CNS and Neurological Disorders - Drug Targets 2014;13:1305-7.

51. Chechneva OV, Mayrhofer F, Daugherty DJ, Krishnamurty RG, Bannerman P, Pleasure DE, Deng W. A Smoothened receptor agonist is neuroprotective and promotes regeneration after ischemic brain injury. Cell Death and Disease 2014;5:e1481.

52. Das S, Rajanikant GK. Huntington disease: Can a Zebrafish trail leave more than a ripple? Neuroscience and Biobehavioral Reviews 2014;45C:258-261.

53. Pradeep H, Rajanikant GK. Computational prediction of a putative binding site on Drp1: Implications for anti-parkinsonian therapy. Journal of Chemical Information and Modeling 2014;54:2042-50.

54. Fayaz SM, Rajanikant GK. Ensemble Pharmacophore Meets Ensemble Docking: A Novel Screening Strategy for the Identification of RIPK1 Inhibitors. Journal of Computer Aided Molecular Design 2014;28:779-94.

55. Pradeep H, Shashikumar S, Rajini PS, Rajanikant GK. Anti-parkinsonian efficacy of target-specific GSK3β inhibitors demonstrated in Caenorhabiditis elegans. Medicinal Chemistry Research 2014;23:5263-68.

56. Hanumanthappa P, Densi A, Krishnamurthy RG. Glycogen synthase kinase-3β in ischemic neuronal death. Current Neurovascular Research 2014;11:271-78.

57. Pradeep H, Rajanikant GK. A comparative molecular dynamics simulation study to assess the exclusion ability of novel GSK3β inhibitors. Medicinal Chemistry Research 2014;23:3092-95.

58. Rajanikant GK, Pretorius E. Editorial: critical appraisal of ischemic stroke pathophysiology: road to cerebral resuscitation? Part I. Current Medicinal Chemistry 2014;21:2023-4.

59. Rajanikant GK, Pretorius E. Editorial: critical appraisal of ischemic stroke pathophysiology: road to cerebral resuscitation? Part II. Current Medicinal Chemistry 2014;21:2119-20.

60. Kumar VS, Gopalakrishnan A, Naziroglu M, Rajanikant GK. Calcium ion – the key player in cerebral ischemia. Current Medicinal Chemistry 2014;21:2065-75.

61. Pradeep H, Sharma B, Rajanikant GK. Drp1 in ischemic neuronal death: An unusual suspect. Current Medicinal Chemistry 2014;21:2183-9.

62. Hanumanthappa P, Rajanikant GK. In silico identification of potential Dynamin-related protein 1 antagonists: Implications for diseases involving mitochondrial dysfunction. Combinatorial Chemistry and High Throughput Screening 2014;17:25-34.

63. Fayaz SM, Suvanish Kumar VS, Rajanikant GK. Necroptosis: Who knew there were so many interesting ways to die? CNS and Neurological Disorders - Drug Targets 2014;13:42-51.

64. Mahesh Kumar Teli, Rajanikant GK. Computational repositioning and experimental validation of approved drugs for HIF-Prolyl Hydroxylase inhibition. Journal of Chemical Information and Modeling 2013;53:1818-24.

65. Nair S, Hagberg H, Krishnamurthy R, Thornton C, Mallard C. Death associated protein kinases: molecular structure and brain injury. International Journal of Molecular Sciences 2013;14:13858-72.

66. Rajanikant GK, Sugunan S. Commentary: Linking productive autophagy to neuroprotection: Potential implications for anti-ischemic therapy. CNS and Neurological Disorders - Drug Targets 2013;12:298-9.

67. Nair SB, Fayaz SM, Rajanikant GK. A novel multi-target drug screening strategy directed against key proteins of DAPk family. Combinatorial Chemistry and High Throughput Screening 2013;16:449-57

68. Sugunan S, Joseph DB, Rajanikant GK. Evolving therapeutic targets in ischemic stroke: A concise review. Current Drug Targets 2013;14:497-506.

69. Rajanikant GK. Editorial: Neuroprotection and neuroregeneration in ischemic stroke: Emerging treatment strategies and potential molecular targets. Current Drug Targets 2013;14:1-2.

70. Teli MK, Krishnamurthy RG. A Combination of 3D-QSAR Modeling and Molecular Docking Approach for the Discovery of Potential HIF Prolyl Hydroxylase Inhibitors. Medicinal Chemistry 2013;9:360-70.

71. Teli MK, Pradeep H, Rajanikant GK. Pharmacophore generation and 3D-QSAR of novel 2-(quinazolin-4-ylamino)-[1,4] benzoquinone derivatives as VEGFR-2 inhibitors. Letters in Drug Design and Discovery 2012;9:899-914.

72. Pradeep H, Rajaniaknt GK. A rational approach to selective pharmacophore designing: An innovative strategy for specific recognition of Gsk3β. Molecular Diversity 2012;16:553–62.

73. Pradeep H, Diya JB, Shashikumar S, Rajanikant GK. Oxidative Stress - assassin behind the ischemic stroke. Folia Neuropathologica 2012;50:219-30.

74. Nair SB, Fayaz SM, Krishnamurthy RG. In silico prediction of novel inhibitors of the DNA binding activity of FoxG1. Medicinal Chemistry 2012;8:1155-62.

75. Teli MK, Rajanikant GK. Pharmacophore generation and atom-based 3D-QSAR of N-iso-propyl pyrrole-based derivatives as HMG-CoA reductase inhibitors. Organic and Medicinal Chemistry Letters 2012;2:25-35.

76. Nair SB, Teli MK, Pradeep H, Rajanikant GK. Computational Identification of Novel Histone Deacetylase Inhibitors by Docking based QSAR. Computers in Biology and Medicine 2012;42:697–705.

77. Bae ON, Rajanikant K, Min J, Smith J, Baek SH, Serfozo K, Hejabian S, Lee KY, Kassab M, Majid A. Lck activation mediates neuroprotection during ischemic preconditioning. Journal of Neuroscience 2012;32:7278-86.

78. Pradeep H, Rajanikant GK. Nano-channels: Biological channel analogues. IET Nanobiotechnology 2012;6:63-70.

79. Hanumanthappa P, Teli MK, Krishnamurthy RG. Generation of pharmacophore and atom based 3D-QSAR model of novel isoquinolin-1-ones and quinazolin-4-ones as potent inhibitors of TNFα. Medicinal Chemistry 2012;8:436-51.

80. Fayaz SM, Rajanikant GK. A critical appraisal of the functional evolution of P2Y12 antagonists as antiplatelet drugs. Current Pharmaceutical Design 2012;18:1625-34.

81. Nair SB, Dileep A, Rajanikant GK. Nanotechnology based diagnostic and therapeutic strategies for neuroscience with special emphasis on ischemic stroke. Current Medicinal Chemistry 2012;19:744-56.

82. Teli MK, Rajanikant GK. Identification of novel potential HIF-Prolyl Hydroxylase inhibitors by in silico screening. Molecular Diversity 2012;16:193-202.

83. Jagetia GC, Rajanikant GK. Acceleration of wound repair by curcumin in the excision wound of mice exposed to different doses of fractionated γ radiation. International Wound Journal 2012;9:76-92.

84. Teli MK, Rajanikant GK. Pharmacophore generation and atom-based 3D-QSAR of novel quinoline-3-carbonitrile derivatives as Tpl2 kinase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 2012;27:558-70.

85. Teli MK, Mutalik S, Rajanikant GK. Nanotechnology and Nanomedicine: Going Small Means Aiming Big. Current Pharmaceutical Design 2010;16:1882-92.

86. Krishnamurthy RG, Senut MC, Zemke D, Min J, Frenkel MB, Greenberg EJ, Yu SW, Ahn N, Goudreau J, Kassab M, Panickar KS, Majid A. Asiatic acid, a pentacyclic triterpene from Centella asiatica, is neuroprotective in a mouse model of focal cerebral ischemia. Journal of Neuroscience Research 2009;87:2541-50.

87. Min J, Senut MC, Rajanikant K, Greenberg E, Bandagi R, Zemke D, Mousa A, Kassab M, Farooq MU, Gupta R, Majid A. Differential neuroprotective effects of carnosine, anserine, and N-acetyl carnosine against permanent focal ischemia. Journal of Neuroscience Research 2008;86:2984-91.

88. Rajanikant GK, Zemke D, Senut MC, Frenkel MB, Chen AF, Gupta R, Majid A. Carnosine is neuroprotective against permanent focal cerebral ischemia in mice. Stroke 2007;38:3023-31.

89. Rajanikant GK, Zemke D, Kassab M, Majid A. The therapeutic potential of statins in neurological disorders. Current Medicinal Chemistry 2007;14:103-12.

90. Jagetia GC, Rajanikant GK, Mallikarjun Rao KV. Ascorbic acid increases healing of excision wounds of mice whole body exposed to different doses of gamma-radiation. Burns 2007;33:484-94

91. Jagetia GC, Rajanikant GK. Curcumin treatment enhances the repair and regeneration of wounds in mice hemi-body exposed to gamma-radiation. Plastic and Reconstructive Surgery 2005;115:515-28.

92. Jagetia GC, Rajanikant GK. Role of curcumin, a naturally occurring phenolic compound of turmeric in accelerating the repair of excision wound in mice whole-body exposed to various doses of gamma-radiation. Journal of Surgical Research 2004;120:127-38.

93. Jagetia GC, Rajanikant GK. Effect of various doses of curcumin on the radiation impaired healing of excision wound in mice: a preliminary study. Journal of Wound Care 2004;13:107-9.

94. Jagetia GC, Rajanikant GK, Baliga MS, Rao KV, Kumar P. Augmentation of wound healing by ascorbic acid treatment in mice exposed to gamma-radiation. International Journal of Radiation Biology 2004;80:347-54.

95. Jagetia GC, Baliga MS, Aruna R, Rajanikant GK, Jain V. Effect of Abana (a herbal preparation) on the radiation-induced mortality in mice. Journal of Ethnopharmacology 2003;86:159-65.

96. Jagetia GC, Rajanikant GK, Rao KVNM. Modulation of radiation-induced delay in the wound healing by ascorbic acid in mice exposed to different doses of hemi-body gamma radiation. Wounds 2003;15:324-38.

97. Chandra Jagetia G, Rajanikant GK, Rao SK, Shrinath Baliga M. Alteration in the glutathione, glutathione peroxidase, superoxide dismutase and lipid peroxidation by ascorbic acid in the skin of mice exposed to fractionated gamma radiation. Clinica Chimica Acta 2003;332:111-21.

98. Jagetia GC, Rajanikant GK, Rao SK. Evaluation of the effect of ascorbic acid treatment on wound healing in mice exposed to different doses of fractionated gamma radiation. Radiation Research 2003;159:371-80.

1. GCP and NDCT rules, issues in research with traditional system of medicine, ICMR national ethics guidelines and role and responsibilities of ethics committee. Department of Homeopathy, GoK and FERCI, 6.8.2022.

2. XLIII All India Cell Biology Conference 2019, IISER Mohali (Punjab), 19-21 December, 2019.

3. Annual Research Symposium. Shriners Hospitals for Children Northern California, USA, 2008.

4. Meeting on Creating Cardiovascular Innovations through Collaboration: Pfizer and Michigan State University, USA, 2004.

5.  International Conference on Natural Products, Free Radicals and Radioprotectors in Health & III Annual Meeting of the Society for Free Radical Research, Tamil Nadu, India, 2004.

6.  International Conference on Radiation Damage and its Modification, New Delhi, India, 2002.

7. International Conference on Emerging Trends in Cancer Research, New Delhi, India, 2002.

8. Satellite Meeting of International Conference on Internal Radiation Dose Management Development and Role of Realistic Biokinetic Models of Actinides and Important Radionuclides in Accurate Dose Measurements, Jaipur, India, 2001.

Book Chapters

1. Rajanikant GK, Guruprasad Kalthur. Growing importance of Zebrafish in translational neuroscience. In "Growing importance of Zebrafish in translational neuroscience". Editor: Prasan R. Bhandari, Springer International, 2021, DOI : 10.1007/978-981-16-5217-2.

2. Neelakandan AR, Maheswari N, Padmanaban VC, Rajanikant GK. Sustainable Bioactive Nanomaterials towards improved water treatment. In "Sustainable bioactive nanomaterials towards improved water treatment ", Editors: Noel Jacob Kaleekkal, Prasanna Kumar S. Mural, Saravanamuthu Vigneswaran, Upal Ghosh. CRS Press, 2021.

3. J Juliana, KL Jesintha, S Mariaamalraj, VC Padmanaban, AR Neelakandan, GK Rajanikant. Can Biopolymers solve the water crisis? Ancient and Modern approaches to wastewater treatment. In “Sustainable Techniques for Water and Wastewater Treatment" Editors: Noel Jacob Kaleekkal, Prasanna Kumar S. Mural, Saravanamuthu Vigneswaran, Upal Ghosh. CRS Press, 2021; 259-274.

4. Jyotirekha Das, Rajanikant GK. NANOvations in neuromedicine for shaping a better future. In “21st Century Nanoscience – A Handbook Nanopharmaceuticals, Nanomedicine, and Food Nanoscience (Volume Eight)”, Klaus D. Sattler (Editor). Taylor & Francis (CRC Press), Pages 10-1 – 10-16, 2020.

5. Gokul S, Rajanikant GK. Circular RNAs in Brain Physiology and Disease. In “Circular RNAs Biogenesis and Functions”, Ed: Junjie Xiao, Advances in Experimental Medicine and Biology, Springer Nature 1087;2018:231-237.

6. Sinoy S. Rajanikant GK. Computational design of multi-target kinase inhibitors. In “Multi-Target Drug Design Using Chem-Bioinformatic Approaches” Roy, Kunal (Ed.) under the Methods in Pharmacology and Toxicology, Springer Nature Switzerland AG, Pages 385-394, 2019.

7. Sreekala S. Nampoothiri, Saurabh A. Jain, David Burrows, Ok-Nam Bae, Arshad Majid and Rajanikant GK. The Molecular Neuroprotective Strategies in Cerebral Ischemia: An Insight into Emerging Treatments for Oxidative Stress. In: Acute Brain Impairment: Scientific Discoveries and Translational Research Editors: Philip V Peplow, Svetlana A Dambinova, Thomas A Gennarelli, Bridget Martinez, Royal Society of Chemistry, UK, Pages 82-104, 2017.

8. Fayaz SM, Majid A, Rajanikant GK. Carnosine-induced neuroprotection. In: Imidazole Dipeptides Chemistry, Analysis, Function and Effects. Victor R. Preedy (Ed), Royal Society of Chemistry, UK, Pages 412-31, 2015.

9. Teli MK, Pradeep H, Mutalik S, Rajanikant GK. Nanotechnology: A Key Facilitator for Personalized Medicine. In: A textbook on Nanotechnology in Health Sciences; Udupa N, Gupta PD (Eds); 2010.

Books

1. Rajanikant GK, Pierre Gressens, Sreekala S. Nampoothiri, Gokul Surendran, Cindy Bokobza. IschemiRs: miRNAs in Ischemic Stroke. ISBN:978-981-15-4797-3; DOI: 10.1007/978-981-15-4798-0, Springer Publications 2020.

1. “Advanced Pedagogy Training” Faculty Development Program, Teaching Learning Centre (IIT Madras), NITC, 2014.

2.  Faculty Development Program on “Bioinformatics - Algorithms, Databases and Tools (BIOADT)”, Dept. of Computer Science & Engineering, NITC, India, 2012.

3.  “Advanced Separation Process” – Faculty Development Program, Dept. of Chemical Engineering, NITC, India, 2010.

4.  IUCEE 2009 Indo US Faculty Leadership Institute workshop on "Effective Teaching; Outcomes based education, Effective Faculty Development". Mysore, India, 2009.

5.  EMBO Workshop Molecular mechanisms of developmental and regenerative biology. Singapore, 11 – 13 November 2018.

6. STEM Teacher Training Workshop on “Research Based Pedagogical Tools”. Sacred Heart College, Kochi. 11-14 Oct, 2017.

7. TEQIP-II sponsored workshop on "Mathematical Modeling on Biology with Matlab Implementation". Department of Mathematics, NITC 18.12.2015.

8. Workshop on “Strategies to attain excellence in impact making research & development”. NITC, 2012.

9. “Workshop on Grant Writing”. Dept. of Computer Science & Engineering, NITC, India, 2012.

10. IUCEE 2009 Indo US Faculty Leadership Institute workshop on "Effective Teaching; Outcomes based education, Effective Faculty Development". Mysore, India, 2009.

11. “Workshop on Bioinformatics”. Dept. of Computer Science & Engineering. NITC, India, 2009.

12.  Management Development Program: “Academic Leadership Program for TEQIP Institutions”. Indian Institute of Management Kozhikode, India, 2014.

13. Distinguished Lecture Program. Indian Institute of Chemical Engineers, Kochi Regional Centre, Calicut, India, 2009.

1. Rajanikant GK, Navami Krishna. Rutin and Linolenic Acid Based Composition to Mimic the Effects of Calorie Restriction for Neurological Disorders. (Application # 202241057999)

2. Sinoy Sugunan, Rajanikant G. K. A pharmaceutical composition consisting 1,4-di(1H-benzimidazol-2-yl)-1,2,3,4-butanetetrol (BTT) as ischemic neuroprotectant. (Application # 201741019943 A).

3. Rajanikant GK, Navami Krishna. LDN193189 and QL-XII-47 Based Composition to Mimic the Effects of Ischemic Preconditioning Against Cerebral Stroke. (Application # 202241058001).

4. Rajanikant GK, Navami Krishna. Dasatinib and Nadolol Formulations as Caloric Restriction Mimetics for Neurological Disorder. (Application # 202241057995).

5. Mini MM, Rasha Rahman PK, Rajanikant GK, Neelakandan AR. A sensor for selective detection of dopamine in real-time. (Application # 202041014799).

6. Rajanikant GK, Navami Krishna. Narciclasine and rosiglitazone Based Composition to Mimic the Effects of Ischemic Preconditioning against Cerebral Stroke. (Application # 202241058000).

7. Rajanikant GK, Navami Krishna. GSK2126458 and Rottlerin Based Composition to Mimicthe Effects of Calorie Restriction for Neurological Disorders. (Application # 202241057997).

8. Mini Mol Menamparambath, Sameena Kanakkayil, Nesleena Puthiyottil, Sijina Kinattingara Parambath, Rajanikant Golgodu Krishnamurthy. Gold-silver alloy embedded PEDOT-based non-enzymatic electrochemical sensor for histamine detection and methods thereof. (Communicated for Patent filing).

9. Rajanikant GK, Navami Krishna. Torin-2 with TWS119 Formulations to Mimic the Effects of Calorie Restriction for Neurological Disorders. (Application # 202241057996).

10. Rajanikant GK, Navami Krishna. Small Molecules with Azacyclonol and Pioglitazone Combinations to Mimic the Effect of Ischemic Preconditioning Against Cerebral Stroke. (Application # 202241057998).

11. Mini Mol Menamparambath, Rasha Rahman P K, Rajanikant G K, Neelakandan A R. A sensor for selective detection of Glutamate in real‐time. (Communicated for Patent filing).

12. Rajanikant GK, Navami Krishna. Tyrphostin AG-1478and Kinetin-Riboside Based Composition to Mimic the Effects of Calorie Restriction for Neurological Disorders. (Application # 202241057994).

Citations    -    3074

h-index       -    31

i10-index    -    59

1. Ok-Nam Bae, Arshad Majid, Rajanikant GK. (Guest Editors). Special Issue "Biologically Active Substances in Cardiovascular and Neurological Diseases". https://www.mdpi.com/journal/ijms/special_issues/Active_substance_Diseases. International Journal of Molecular Sciences, 2020.

2. Rajanikant GK, Pretorius E. Editorial: critical appraisal of ischemic stroke pathophysiology: road to cerebral resuscitation? Part I. Current Medicinal Chemistry, 2014;21:2023-4.

3. Rajanikant GK, Pretorius E. Editorial: critical appraisal of ischemic stroke pathophysiology: road to cerebral resuscitation? Part II. Current Medicinal Chemistry, 2014;21:2119-20.

4. Rajanikant GK. Editorial: Neuroprotection and neuroregeneration in ischemic stroke: emerging treatment strategies and potential molecular targets. Current Drug Targets, 2013;14:1-2.

1. Charles K. Davis, Rajanikant G. K. Post-ischemic supplementation of Folic acid improves neuronal survival and regeneration in vitro. XLIII All India Cell Biology Conference 2019, IISER Mohali (Punjab), 19-21 December, 2019.

2. Rajanikant Krishnamurthy, Sreekala Nampoothiri, miR-9 involvement in post-ischemic neuroprotection and neurite outgrowth. EMBO Workshop Molecular mechanisms of developmental and regenerative biology. 11 – 13 November 2018, Singapore.

3. Sreekala S. Nampoothiri, Rajanikant GK. A Novel Five-Node Feed-Forward Loop Delves into the Molecular Mechanism of Ischemic Stroke. Science Trends, March 23, 2018 (https://sciencetrends.com/a-novel-five-node-feed-forward-loop-delves-into-the-molecular-mechanism-of-ischemic-stroke/).

4. Sreekala S. Nampoothiri, Rajanikant GK. Evaluating Rodent Aerobics For Preclinical Ischemic Stroke Intervention Assessments. Science Trends, February 1, 2018 (https://sciencetrends.com/?p=10161&preview=1&_ppp=b78fef8afa).

5. Jyotirekha Das, Rajanikant GK. Prioritizing drug repositioning strategy to ensure ischemic neuroprotection. The 11th FENS Forum of Neuroscience (FENS 2018). July, 2018, Berlin, Germany.

6. C. Kozhikkadan Davis, R. G.K. Folic Acid Exerts Post-Ischemic Neuroprotection In Vitro Through HIF-1α Stabilization. 10th International Symposium on Neuroprotection and Neurorepair (ISN&N). October, 2018, Dresden, Germany.

7. Sreekala S Nampoothiri, Rajanikant G K. CUSAT-NUS Joint International Conference on Biotechnology and Neuroscience. December 2016, Kochi, India.

8. Charles K Davis, Rajanikant G K. Repurposed FDA approved drugs confer post-ischemic neuroprotection through HIF-1 Prolyl and Asparaginyl hydroxylase inhibition. CUSAT-NUS Joint International Conference on Biotechnology and Neuroscience. December 2016, Kochi, India.

9. Nampoothiri S., Fayaz S. M., Rajanikant G. K. A novel 5-node feed forward loop to generate robust miRNA-TF regulatory network for cerebral ischemia. 9th International Symposium on Neuroprotection and Neurorepair, Leipzig, Germany, April, 2016 [http://www.neurorepair-2016.de/scientific_content/poster_overview.html].

10. Surya S. Singh, Ravi Kumar Eslavath, Deepshikha Sharma, Nabil A. M. Bin Omar, Rajasekhar Chikat, Mahesh Kumar Teli, and G. K. Rajanikant. β-N-oxalyl-L-α, β- diaminopropionic acid induces HRE expression by inhibiting HIF-prolyl hydroxylase-2 in normoxic conditions. International Conference on Agricultural, Civil and Environmental Engineering (ACEE-16), Istanbul, Turkey, 2016.

11. Shashikumar Shivaiah, Rajanikant Golgodu Krishnamurty. PUFA therapy ameliorates Parkinson disease like symptoms. 19th International C. elegans Meeting, Los Angeles, USA, 2013.

12. Rajanikant Krishnamurthy, Wenbin Deng. Sargahydroquinoic acid and its acetylated derivative are novel neuroprotective agents against injury induced by focal cerebral ischemia. 38th annual meeting of the Society for Neuroscience, Washington, USA, 2008.

13. Gursurinder Pal Kaur, Vimal Selvaraj, Rajanikant Krishnamurthy, Wenbin Deng. The role of PARP-1 gene deletion in the development of experimental autoimmune encephalomyelitis. 38th annual meeting of the Society for Neuroscience, Washington, USA, 2008.

14. Krishnamurthy R, Zemke D, Majid A. Asiatic acid is neuroprotective in a mouse model of stroke. 23rd International Symposium on Cerebral Blood Flow, Metabolism and Function. Osaka, Japan, 2007. 

15. Majid A, Krishnamurthy R, Zemke D. Carnosine inhibits matrix metalloproteinase activity both in vitro and in vivo in brain after cerebral ischemia. 36th annual meeting of the Society for Neuroscience, Atlanta, USA, 2006.

16. Zemke D, Krishnamurthy R, Farooq MU, Reeves MJ, Chen AF, Majid A. The effect of hypoxic preconditioning on the mTOR pathway. International Stroke Conference, Florida, USA, 2006 Stroke 2006;37(2):682.

17. Zemke D, Krishnamurthy R, Majid A. Carnosine is neuroprotective in a mouse model of stroke.  XXIInd International Symposium on Cerebral Blood Flow, Metabolism, and Function. Amsterdam, Amsterdam, The Netherlands. June 7-11, 2005. Journal of Cerebral Blood Flow & Metabolism 2005; 25:S313.

• Invited Talk “A Roadmap for Research in Translational Neuroscience”. Continuing Medical Education Program on “Homeopathic Evidence based Advanced Research and Training (HEART)” as part of the World Hahnemannian Day Celebrations, commemorating the 267th Birth Anniversary of Dr. Samuel Hahnemann. The Directorate of Homoeopathy, Department of AYUSH, Government of Kerala, April 12, 2022.

• Invited Talk “Computational drug repurposing for ischemic stroke”, 1st Virtual International Workshop on Insights in Pharmacological and Pharmaceutical Sciences, BK21 FOUR Education and Research Center for Problem Solving Leaders in Pharma Industry, Hanyang University, South Korea, January 29th, 2021.

• Keynote Speaker. “Drug Repurposing for Ischemic Stroke”, SYMBIOT 2019 – A National Symposium in Biotechnology, Manipal Institute of Technology, Manipal, September 26, 2019.

• Invited talk “miRNomics: The rise of microRNA research”. National Workshop on Frontier areas of Plant Biotechnology, Centre for Plant Biotechnology and Molecular Biology, College of Horticulture, Kerala Agricultural University, Thrissur, 21 – 30 November, 2018.

• Invited Talk, “Therapeutic drug repurposing for ischemic stroke”. 36th Annual Meeting of Indian Academy of Neurosciences (IAN), Banaras Hindu University, Varanasi, 29-31 October 2018.

• Invited Talk, “Therapeutic Drug Repurposing for Ischemic Stroke”. Innovations in Drug Discovery and Drug Delivery (IDD2018), T. John College of Pharmacy, Bangalore, 23 March, 2018.

• Invited Talk, “Angiotensin II confers ischemic neuroprotection in vitro through inhibiting miR-497 maturation”. International Conference of Toxicology and Clinical Pharmacology” in Rome, Italy, December 14-16, 2017.

• Invited Talk, “Career & educational options after +2”, Bina Vaidya International Public School, Murdeshwara, India, 2016.

• Resource Person, AICTE sponsored seminar cum workshop “Nanomedicines: Risk and Benefit Ratio”, Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal University, India, 2014.

• Resource Person, UGC sponsored “Training Programme for Researchers in Science”, University of Calicut, India, 2013.

• Resource Person, Faculty Development Program on “Bioinformatics - Algorithms, Databases and Tools (BIOADT)”, Dept. of Computer Science and Engineering, NITC, India, 2012.

• Invited Talk, NSF, IUSSTF and DBT sponsored “Indo-US Workshop on Biocomputing (ISB-2011)”, NITC, India, 2011.

• Resource Person, AICTE sponsored national seminar “Emerging Trends in Nanoparticle Characterization Techniques – Need for Harmonization”, Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal University, India, 2011.

• Resource Person, “Trends and Techniques in Nano Technology”– Faculty Development Program, School of Nanoscience & Technology, NITC, India, 2010.

• Invited Talk, “Nanobiotechnology: SMALL Science, BIG Consequences”, Nanobiotechnology Summer School, Africa City of Technology, Sudan, Africa, 2010.

• Chairperson, Centre for Students Activity and Sports (CSAS), NITC, Oct, 2022 - present.

• Chairperson, Centre for Cultural and Art Relations (CCAR), NITC, Feb 2022 - present.

• Dean (Students’ Welfare), NITC Nov 2021 – present.

• Warden, B-Hostel, NITC, August 2021 – Oct. 2021.

• President, Faculty Association of NITC, 2021.

• Department Coordinator - PTA, SBT, 2020.

• Served as UG Class Committee Chairman, SBT, 2018 – 2020.

• Served as Head of the Department, SBT, Nov. 2017 – Nov. 2019.

• Served as Departmental Purchase Coordinator, SBT, 2017 – 2018.

• Member, Inspired Teacher Network, NITC, 2016 – present.

• Served as Faculty Advisor, B.Tech 2016 - 2020 Batch.

• NBA Coordinator, SBT, NITC, 2015 - 2019.

• Served as Coordinator, DBT - Bioinformatics Infrastructure Facility, SBT, NITC, 2010 - 2018.

• Served as Head of the Department, SBT, NITC, Oct, 2013 – Oct, 2015.

• Served as Warden, A-Hostel, NITC, 2014 - 2016.

• Served as Faculty Advisor, Students’ Guidance Cell, NITC, 2012 - 2014.

• Served as PhD Course coordinator, SBT, NITC, 2009 - 2013.

• Served as Member, Library Advisory Committee, NITC, 2013.

• Served as Member, Curriculum Revision Committee, NITC, 2013.

• Served as Warden, G-Hostel, NITC, 2011 - 2013.

• Served as Warden, B-Hostel, NITC, 2010 - 2011.

• Served as Member, Curriculum Revision Committee, NITC, 2010.

• Served as Warden, G-Hostel, NITC, 2009 - 2010.

• Life Member, Indian Academy of Neurosciences, India.

• Expert member of “Programme Advisory Committee - Young Investigator's Programme in Biotechnology (PAC-YIPB), Kerala State Council for Science, Technology and Environment (KSCSTE), Kerala, Nov 2022.

• Expert member, Institutional Ethical Committee, Department of Homeopathy, Kerala, 2022.

• Peer Team Member (Assessors), National Assessment and Accreditation Council (NAAC), an autonomous body funded by the University Grants Commission (UGC).

• Expert Member, Research Advisory Board (RAC), Malabar Medical College Hospital & Research Centre, Kozhikode, 2021 - present.

• Academic Editor, PLOS ONE Editorial Board.

• Section Editor - Current Frontiers section, CNS & Neurological Disorders - Drug Targets, Bentham Science Publishers.

• External Member, Department Curriculum Committee, Department of Biotechnology, Manipal Institute of Technology, MAHE, Manipal, India.

• Served as Chairman, Institutional Ethical Committee, Department of Homeopathy, Kerala 2020-2022.

• Served as International Grant Evaluator for the National Research Foundation (NRF), South Africa, 2022.

• Served as Peer Reviewer for the Research and Innovation projects, Leeds Hospitals Charity, Leeds, UK, 2022.

• Served as Evaluator for the Young Innovators Program (YIP) 2020-21, KDISC, Govt. of Kerala, 2021.

• Served as International Grant Reviewer, Fundación Bancaria Caixa d'Estalvis i Pensions de Barcelona, “la Caixa”, 2021.

• Served as Panel Judge in District Level Evaluation for Young Innovators Program 2019, Kerala Development Innovation Strategic Council (KDISC), Govt. of Kerala, 29^th October and 9^th November, 2019 in Kannur and Calicut.

• Served as Mentor for the Young Innovators Program (YIP) 2018-21, KDISC, Govt. of Kerala.

• Served as International Grant Reviewer, The Research Council (TRC) of the Sultanate of Oman, Oman, 2020.

• Served as a Member of Expert Panel for Technical Paper Evaluation, 31st Kerala Science Congress, 2018.

• Served as International Grant Reviewer, Czech Science Foundation, the Czech Republic.

• Served as Reviewer, Cellular and Molecular Neurobiology, Springer, 2018.

• Served as Reviewer, Scientific Reports, Nature Research Journal, 2018.

• Served as Abstract Grader, The 2019 International Stroke Conference and Stroke Nursing Symposium, Honolulu, HI.

• Served as Reviewer, Nature Communications, Nature Research Journal, 2018.

• Served as Jury, Biotechnology Sector, Kerala Startup Mission, Indian Institute of Management Kozhikode, February 5, 2018.

• Served as External Evaluator of Doctoral Thesis, University of Pretoria, South Africa, 2017.

• Served as International Grant Reviewer, Cancer Association of South Africa, South Africa, 2017.

• Served as International Grant Reviewer, The Stroke Association, UK, 2017.

• Served as a Member of Expert Panel for Technical Paper Evaluation, 28th Kerala Science Congress, January 2016.

• Served as Jury - Yuva Mastermind 2016 – A Joint venture of Malayalam Manorama, IBS and Amal Jyothi College of Engineering, Kottayam, Jan 2016.

• Served as External Evaluator and Examiner of Doctoral Thesis, Birla Institute of Technology & Science (BITS), Hyderabad, 2015.

• Served as External Evaluator of Doctoral Thesis, University of Pretoria, Pretoria, South Africa, 2015.

• Served as Member of UGC Expert Committee to visit Noida International University, Noida, 2015.

• Served as External Evaluator of Doctoral Thesis, Univrsity of Pretoria, South Africa, 2013.

• Served as Reviewer, PLOS ONE, PLOS.

• Served as Reviewer, Nanomedicine: Nanotechnology, Biology, and Medicine (Nanomedicine: NBM), Elsevier.

• Served as Reviewer, Molecular Pharmaceutics, ACS Publications.

• Served as Reviewer, Chinese Journal of Integrative Medicine, Springer.

• Served as Reviewer, Medicinal Chemistry Research, Springer.

• Served as Reviewer, Pharmaceutical Research, Springer.

• Served as Grant Reviewer, Department of Biotechnology – Neurobiology Task-force, Govt. of India, New Delhi, India.

• Served as Associate Editor, BMC Research Notes.

• Served as International Grant Reviewer, Thuthuka Programme, National Research Foundation (NRF), Pretoria, South Africa.

• Served as International Grant Reviewer, Estonian Science Foundation, Endla 4, 10142 Tallinn, Estonia.

• Served as Grant Reviewer, Indian Council of Medical Research, Govt of India, New Delhi, India.

• Served as Organizing Chair, Indo-US Workshop on Biocomputing (ISB-2011), NIT Calicut, 2011.

• Served as Member of Organizing Chairs committee, International Symposium on Biocomputing (ISB 2010), NIT Calicut, India, 2010.

• Served as Coordinator for Biotechnology Teaching Excellence Program 2010 (BTEP 2010) - Faculty Development Program, School of Biotechnology, NIT Calicut, India, 2010.